Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VRXA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
VRXA
Veraxa Biotech AG - Post de-SPAC
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
VRXA
Veraxa Biotech AG - Post de-SPAC
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
VRXA: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VRXA
0
None
Shared
0
No disclosed counterparties: VRXA.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VRXA, solid
LLY, dashed
VRXA
Veraxa Biotech AG - Post de-SPAC
Change
1.16
▲
+12.53%
· post 0.99
· delayed
Mkt cap
$14.9M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,407.25
▼
−0.27%
· post 1,407.52
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 3 '26
delayed
VRXA
Veraxa Biotech AG - Post de-SPAC
vs
LLY
ELI Lilly & Co
1.16
▲
+12.53%
post 0.99
delayed
Price
1,407.25
▼
−0.27%
post 1,407.52
delayed
$14.9M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
VRXA
1.16
▲
+12.53%
vs
LLY
1,407.25
▼
−0.27%
After hours
Nov 3 '26
delayed